Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

Clinical trial NCT00675025 · TERMINATED

Trial details

NCT number

NCT00675025

Sponsor

Eisai Inc.

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2008-04-04

Primary completion

2008-11-13

Enrollment

117

View on ClinicalTrials.gov